COMP <GO>
ELDN vs ACIU // FREE CASH FLOW YIELD
Eledon Pharmaceuticals Inc. (NASDAQ) VS. AC Immune SA (NASDAQ) • 15-METRIC TALLY: ELDN 2
— ACIU 0
■ METRIC PARITY
LAST: $3.04 (+10.15%) • MKT CAP: $247.0M
fcf-yield
—
LAST: $2.37 (0.00%) • MKT CAP: $241.2M
fcf-yield
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELDN VS. ACIU)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELDN | ACIU | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.0 | 36.2 | +21.81 | ELDN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $247.0M | $241.2M | $5.8M | ELDN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELDN REV | ACIU REV | ELDN GROSS % | ACIU GROSS % | ELDN FCF | ACIU FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | — | — | — | -$62.3M | — |
| FY 2024 | $0 | — | — | — | -$47.3M | — |
| FY 2023 | $0 | — | — | — | -$39.5M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELDN // BETA —
ACIU // BETA —